← Back to headlines
Analyst Highlights Emerging Pharmaceutical Competitor in the Booming GLP-1 Weight Loss Market
Financial commentator Jim Cramer identifies a lesser-known pharmaceutical candidate poised to capture significant market share alongside established leaders like Eli Lilly in the rapidly expanding weight-loss drug sector.
1 Sept, 12:45 — 1 Sept, 12:45
Sources
Showing 1 of 1 sources
